Contact Us
Company Contact
Latha Poonamallee
CEO
906-231-1135
drlatha@inmed.ai

More »

In-Med Prognostics is a pioneer in AI-driven predictive analytics using multi-modal data, including text, signal, and image and the creator of an end-to-end fully automated organ agnostic imaging platform at work in over 220+ sites in India, Africa, and the Middle East. With deep expertise in developing, deploying, and managing fully automated image processing algorithms and pipelines using AI/ML, our capabilities also include building and deploying tools for remote site monitoring, providing both central and site-based access to medical imaging data, dynamic dashboards, and imaging data visualization at sites of care and clinical trials. We continue to expand the product suites in CT Brain applications, Whole Body MRI/video Wellness/Athletic solutions, and lesion solutions for pancreatic and liver cancer.

https://inmed.ai

News Releases
Nov 13, 2023

Chicago, Nov 13, 2023 -- InMed.AI (InMed Prognostics Inc.), a pioneer in AI-driven predictive analytics using multi-modal data including text, signal, and image (US Patent No.11263749) and the...

More »